All Stories

Prime Medicine CEO exits as biotech shelves sole clinical gene therapy, lays off staff

Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine and laying off an undisclosed number of staffers.

May 19, 2025 - 20:10
 0
Prime Medicine CEO exits as biotech shelves sole clinical gene therapy, lays off staff
Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine and laying off an undisclosed number of staffers.
Read More

Tags:

Previous Article

For Eisai and Biogen's Leqembi, first FDA-approved Alzheimer's blood test will t...

Next Article

STAT+: GOP works through unresolved issues on Medicaid work requirements

Related Posts

GSK pays $1.2B upfront for Boston Pharmaceuticals' lead liver disease drug

GSK pays $1.2B upfront for Boston Pharmaceuticals' lead...

May 14, 2025  0

Fierce Biotech Layoff Tracker 2025: Leap halves team; Atara lays off 30% of staffers

Fierce Biotech Layoff Tracker 2025: Leap halves team; A...

May 13, 2025  0

Leap halves head count, narrows lead cancer drug's focus amid 'difficult market environment'

Leap halves head count, narrows lead cancer drug's focu...

May 13, 2025  0